Andreas Busch

Director/Board Member at SUN PHARMACEUTICAL INDUSTRIES LTD.

Net worth: 5 M $ as of 2026-06-29

63 year

77 connections

Health Technology

Consumer Services

Commercial Services

Profile

Andreas Eugen Busch is an Independent Outside Director at Astellas Pharma, Inc. since 2025 and an Independent Director at Sun Pharmaceutical Industries Ltd. since 2026.
Former roles include Vice Chairman-Supervisory Board at Centogene NV from 2022 to 2023, Chief Scientific Officer & Executive VP at Shire Plc from 2018 to 2019, Chief Scientific Officer at Cyclerion Therapeutics, Inc. from 2021 to 2022, Chief Innovation Officer at Absci Corp.
from 2022 to 2026, Head-Global Drug Discovery at Bayer Pharma AG from 2016 to 2017, Executive Vice President & Head-Drug Discovery at Bayer Animal Health from 2016 to 2017, Executive VP & Head-Global Drug Discovery at Bayer HealthCare AG from 2006 to 2015, Head-Cardiovascular Research at Aventis Pharma AG in 2005, Head-Cardiovascular Research at Hoechst Marion Roussel, Inc. from 1997 to 1999, and Global Head-Cardiovascular Research at Sanofi-Aventis Groupe SA from 1997 to 2005.
Also served as Professor at Johann Wolfgang Goethe-Universität Frankfurt am Main and Member-Supervisory Board at Max-Delbrück-Centrum für Molekulare Medizin (MDC).
Education includes a doctorate from Johann Wolfgang Goethe-Universität Frankfurt am Main conferred in 1989.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
ABSCI CORPORATION 0.25%	2026-03-30	421,446 ( 0.25% )	5 M $	2026-06-29

Andreas Busch active positions

Companies	Position	Start
SUN PHARMACEUTICAL INDUSTRIES LTD.	Director/Board Member	2026-05-11

All active positions of Andreas Busch

Former positions of Andreas Busch

Companies	Position	End
ABSCI CORPORATION	Director/Board Member	2022-10-03
CENTOGENE N.V.	Director/Board Member	2023-12-11
CYCLERION THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	2022-09-29
SHIRE	Chief Tech/Sci/R&D Officer	2019-02-28
Bayer Pharma AG Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Corporate Officer/Principal	2017-11-30

See the detail of Andreas Busch's experience

Training of Andreas Busch

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Andreas Busch's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	14
Shire Plc Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases	Health Technology
Sun Pharmaceutical Industries Ltd. Sun Pharmaceutical Industries Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical ingredients	Health Technology
Bayer HealthCare AG Bayer HealthCare AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals, healthcare supplements and crop herbicides	Health Technology
Astellas Pharma, Inc. Astellas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals and related medical products	Health Technology
Johann Wolfgang Goethe-Universität Frankfurt am Main Johann Wolfgang Goethe-Universität Frankfurt am Main Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Bayer Pharma AG Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
Aventis Pharma AG
Hoechst Marion Roussel, Inc. Hoechst Marion Roussel, Inc. Pharmaceuticals: GenericHealth Technology Develops, manufactures and sells generic pharmaceutical products	Health Technology
Max-Delbrück-Centrum für Molekulare Medizin (MDC) Max-Delbrück-Centrum für Molekulare Medizin (MDC) Miscellaneous Commercial ServicesCommercial Services Operates as a biomedical research institute	Commercial Services
Bayer Animal Health Bayer Animal Health Pharmaceuticals: MajorHealth Technology Provides healthcare and pharmaceutical medicines	Health Technology
Sanofi-Aventis Groupe SA Sanofi-Aventis Groupe SA Financial ConglomeratesFinance Functions as an investment holding company	Finance
Absci Corp. Absci Corp. BiotechnologyHealth Technology Engages in development of cutting-edge protein production technologies committed to reducing costs in the biopharmaceutical industry	Health Technology
Cyclerion Therapeutics, Inc. Cyclerion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products for serious and orphan diseases	Health Technology
Centogene NV Centogene NV Medical SpecialtiesHealth Technology Provides genetic diagnostic analyses of rare inherited diseases	Health Technology